期刊文献+

细胞穿膜肽pep-1与vMIP-Ⅱ的融合表达与纯化 被引量:4

The Fusion Expression and Purification on Cell Permeable Peptide pep-1 and Viral Macrophage Inflammatory Protein-Ⅱ
下载PDF
导出
摘要 细胞穿膜肽是一类能携带大分子物质进入细胞的短肽,其穿膜能力不依赖经典的胞吞作用。本研究构建了含有细胞穿膜肽pep-1和病毒巨噬细胞炎症蛋白-Ⅱ(viral macrophage inflammatory protein-Ⅱ,vMIP-Ⅱ)的融合表达质粒pET15b-pep-1-vMIP-Ⅱ,并将其转化大肠杆菌BL21(DE3)plysS中经IPTG诱导表达,经SDS-PAGE和Western-blot鉴定出可溶性的融合蛋白pep-1-vMIP-Ⅱ。通过对IPTG浓度、温度等诱导表达条件进行优化,确定在IPTG浓度为0.2mmol/L、28℃下诱导7h可溶性蛋白的表达量相对较高,经Ni-NTA亲和层析,超滤除盐纯化获得高纯度的融合蛋白pep-1-vMIP-Ⅱ,将该蛋白作用于Hela细胞,激光共聚焦显微镜观察结果显示该融合蛋白能够携带目的基因穿透细胞膜。本文结果将为进一步研究vMIP-Ⅱ的功能和细胞穿膜肽技术的应用奠定基础。 Cell permeable peptide is a kind of small peptides that are capable of bringing micromolecules into cell memebrane,the cell permeation ability of which is independent of classic endocytosis.In this article,the plasmid pET15b-pep-1-vMIP-Ⅱ,synthesis from cell permeable peptide pep-1 and viral macrophage inflammatory protein-Ⅱ,was transducted into Escherichia coli BL21(DE3) plysS.The expression product induced by IPTG was identified and analysed by SDS-PAGE and Western-blot.The optimization of expression condition such as the concentration of IPTG and temperature led to the relatively highest expression level of soluble protein was at the circumstance of 7 hours of inducement under the condition of 0.2 mmol/L concentration of IPTG and 28℃.Fusion protein of high purity was cleaned by hyperfiltration after Ni-NTA affinity chromatography.When the fusion protein acted on the Hela cell,the function of carry target gene and penetrating cell membrane was abserved through LSCM.The results of this would lay the foundation for further research of the function of vMIP-Ⅱ and the application of cell cermeable technique.
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2010年第6期1026-1032,共7页 Genomics and Applied Biology
基金 浙江省科技厅国际合作重点项目(2008C14G2150010) 杭州师范大学中青年培育基金(2010QN31)共同资助
关键词 vMIP-Ⅱ PEP-1 细胞穿膜肽 原核表达 vMIP-Ⅱ pep-1 Cell permeable peptides Prokaryotic expression
  • 相关文献

参考文献17

  • 1Boshoff C.,Endo Y.,Collins P.D.,Takeuchi Y.,Reeves J.D.,Schweickart V.L.,Siani M.A.,Sasaki T.,Williams T.J.,Gray P.W.,Moore P.S.,Chang Y.,and Weiss R.A.,1997,Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines,Science,278(5336):290-294.
  • 2Chen S.,Bacon K.B.,Li L.,Garcia G.E.,Xia Y.,Lo D.,Thompson D.A.,Siani M.A.,Yamamoto T.,Harrison J.K.,and Feng L.,1998,In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-Ⅱ,J.Exp.Med.,188 (1):193-198.
  • 3Cherqui S.,Kingdon K.M.,Thorpe C.,Kurian S.M.,and Salomon D.R.,2007,Lentiviral gene delivery of vMIP-Ⅱ to transplanted endothelial cells and endothelial progenitors is proangiogenic in vivo,Mol.Ther.,15(7):1264-1272.
  • 4Dairaghi D.J.,Fan R.A.,McMaster B.E.,Hanley M.R.,and Schall T.J.,1999,HHV8-encoded vMIP-Ⅰ selectively engages chemokine receptor CCR8.Agonist and antagonist profiles of viral chemokines,J.Biol.Chem.,274(31):21569-21574.
  • 5Killian D.M.,Gharat L.,and Chikhale P.J.,2000,Modulating blood-brain barrier interactions of amino acid-based anticancer agents,Drug Deliv.,7(1):21-25.
  • 6Kledal T.N.,Rosenkilde M.M.,Coulin F.,Simmons G.,Johnsen A.H.,Alouani S.,Power C.A.,Lüttichau H.R.,Gerstoft J.,Clapham P.R.,Clark-Lewis I.,Wells T.N.,and Schwartz T.W.,1997,A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus,Science,277(5332):1656-1659.
  • 7Lindgren M.,Hallbrink M.,Prochiantz A.,and Langel U.,2000,Cell-penetrating peptides,Trends Pharmacol.Sci.,21 (3):99-103.
  • 8Lüttichau H.R.,Stine J.,Boesen T.P.,Johnsen A.H.,Chantry D.,Gerstoft J.,and Schwartz T.W.,2000,A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum,J.Exp.Med.,191(1):171-180.
  • 9Morris M.C.,Depollier J.,Mery J.,Heitz F.,and Divita G.,2001,A peptide carrier for the delivery of biologically active proteins into mammalian cells,Nat.Biotechnol.,19(12):1173-1176.
  • 10Morris M.C.,Vidal P.,Chaloin L.,Heitz F.,and Divita G.,1997,A new peptide vector for efficient delivery of oligonucleotides into mammalian cells,Nucleic Acids Res.,25(14):2730-2736.

二级参考文献35

  • 1杨宇,吴江,杨欣,胡林森.NT4-NAP融合基因原核表达载体的构建及在大肠杆菌中的表达[J].中华神经科杂志,2004,37(3):260-261. 被引量:17
  • 2吴昊,吴江.蛋白质转导域在医学中的研究与应用[J].中风与神经疾病杂志,2005,22(6):566-568. 被引量:2
  • 3[1]MACDONALD MR,LY XY,V1RGIN IV HW. Late expression of a beta chemokine homolog by murine cytomegalvirus [J]. J Virol, 1997, 71 (2): 1 671-1 678.
  • 4[2]MACDONALD MR,BURNEY MW,RESNICK SB. Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure[J]. J Virol, 1999,73(5):3 682-3 691.
  • 5[3]SAEDERUP N, LIN YC, DAIRAGHI DJ. Cytomega-lovirus-encoded β chemokine promotes monocyte-as-sociated viremia in the host [J]. Proc Natl Acad Sci USA,1999,96(19):10 881-10 886.
  • 6[4]PENFOLD ME , DAIRAGHI DJ , DUKE GM . Cytomegalovirus encodes a potent α chemokine[J]. Proc Natl Acad Sci USA,1999,96(17):9 839-9 844.
  • 7[5]GAO JL , MURPHY PM . Human cytomegalovirus open reading frame US28 encodes a functional β chemokine receptor [J]. J Biol Chem, 1994,269 (46): 28 539-28 542.
  • 8[6]BILLSTROM MA,JOHNSON GL, AVDI NJ. Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection[J]. J Virol,1998,72(7):5 535-5 544.
  • 9[7]PLESKOFF O,TREBOUTE C,BRELOT A. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry [J].Science, 1997,276(5 320) .. 1 874-1 878.
  • 10[8]PLESKOFF O,TREBOUTE C,ALIZON M. The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins[J]. J Viro1,1998.72(8):6 389-6 397.

共引文献13

同被引文献21

  • 1王峰,孙晗笑.趋化因子及其受体与艾滋病的研究进展[J].中国新药杂志,2007,16(16):1243-1246. 被引量:1
  • 2Malim Mh,Bieniasz Pd.HIV Restriction Factors and Mechanisms of Evasion[J].Cold Spring Harb Perspect Med,2012,2(5):a006940.
  • 3Harris Rs,Hultquist Jf,Evans Dt.The restriction factors of humanimmunodeficiency virus[J].J Biol Chem,2012,287(49):40875-40883.
  • 4Harris Rs,Bishop Kn,Sheehy Am,et al.DNA deamination mediatesinnate immunity to retroviral infection[J].Cell,2003,113(6):803-809.
  • 5Jarmuz A,Chester A,Bayliss J,et al.An anthropoid-specific locus oforphan C to U RNA-editing enzymes on chromosome 22 [J].Genomics,2002,79(3):285-296.
  • 6Zheng Yh,Irwin D,Kurosu T,et al.Human APOBEC3F is anotherhost factor that blocks human immunodeficiency virus type 1replication[J].J Virol,2004,78(11):6073-6076.
  • 7Chang Y,Cesarman E,Pessin Ms,et al.Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi'ssarcoma[J].Science,1994,266(5192):1865-1869.
  • 8Zheng Yh,Jeang Kt,Tokunaga K.Host restriction factors in retroviralinfection:promises in virus-host interaction[J].Retrovirology,2012,9(112):45-73.
  • 9Wolf D,Goff Sp.Host restriction factors blocking retroviralreplication[J].Annu Rev Genet,2008,42:143-163.
  • 10Harris Rs.Enhancing immunity to HIV through APOBEC[J].Nat Biotechnol,2008,26(10):1089-1090.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部